Consenting for current genetic research: is Canadian practice adequate?

Area of Science:

• Biomedical Ethics
• Genetic Research Policy

Background:

• Assessing the impact of new technologies like Next Generation Sequencing (NGS) is crucial for protecting research participants.
• Ethical and legal frameworks, including informed consent, require reevaluation in light of advancements in genetic research.
• Institutional Review Boards (IRBs) must ensure participants are adequately informed about the realities of genetic research.

Purpose of the Study:

• To analyze Canadian informed consent templates and IRB instructions for genetic research involving Next Generation Sequencing (NGS).
• To identify key themes and potential improvements in the consent process for genetic research.
• To assess the adequacy of current consent modalities for secondary data use, material sharing, and participant recontact.

Main Methods:

• Content analysis of Canadian Informed Consent templates and IRB instructions for genetic research.
• Examination of research ethics policies from Canadian research agencies (Tri-Council Policy Statement, 2nd Edition).
• Review of IRB-approved consent forms for genetic studies on brain and mental health disorders.

Main Results:

• Eighty percent of documents discussed secondary use of materials/data, but inconsistently.
• Information on independent sharing of genetic sequencing data was lacking.
• Limited grounds for recontacting participants were identified, primarily for secondary use consent.
• Specific consent forms for brain/mental health genetic studies provided comprehensive details on data/material sharing and database use.

Conclusions:

• Canadian NGS research protocols currently address many participant protection needs.
• Recommendations include adding defined categories for future use, enhancing options for genetic data sharing, and broadening reasons for participant recontact.